Programme

PRELIMINARY PROGRAMME
(original programme of 2020, changes possible)

Thursday                   

08:30-09:00    Opening Ceremony
.                        (Marcus Hacker – MUW, Martin Jung – AIT)

Speakers:       Michaela Fritz (MUW)
.                        Wolfgang Knoll (AIT)

09:00-09:30    Keynote Lecture

The New Diagnostic Concept in Oncology: From cells to systems” (Klaus Pantel, Hamburg)

09:30-11:00    Liquid Biopsy Diagnostics
                        Chairs: G. Egger, A. Weinhäusel 

  1. 09:30 – 09:55 RNA in Liquid Biopsies for Precision Medicine Purposes
    (Jo Vandesompele; Ghent)
  2. 09:55 – 10:20 A market perspective on the future of liquid biopsies
    (Christian Hense, Universal Dx)
  3. 10:20 – 10:45 Current and future perspectives of liquid biopsies in genomics-driven oncology (Ellen Heitzer, Graz)
  4. 10:45 – 11:00 Early detection of pancreatic cancer recurrence by identifying specific protein signatures in peripheral blood (Fawaz Al-Shaheri, GE)

11:00-11:30    Coffee Break

11:30-13:00    Whole Organism Imaging
                        Chairs: T. Beyer, C. Gebhart

  1. 11:30 – 11:55 Large Field of View PET: Revolution in Molecular Imaging
    (Sibylle Ziegler, Munich)
  2. 11:55 – 12:20 Imaging Biomarker Development (Andreas Kjaer, Copenhagen)
  3. 12:20 – 12:45 Imaging humoral and cellular Inflammation (Bernd Pichler, Tübingen)
  4. 12:45 – 13:00 Gene Regulatory Networks in Metabolic Syndrome (Frank Staubli, CH)

13:00-14:30    Lunch plus Posters

14:30-16:00    Biomarkers and/or Systemic Signalling Pathways
                        Chairs: W. Neuhaus, V. Zinzalla

  1. 14:30 – 14:55 Tumor-Organ Communication (Erwin Wagner, Vienna)  
  2. 14:55 – 15:20 Heart-Brain Axis (Frank Bengel, Hannover)
  3. 15:20 – 15:45 Disease-Disease Relationship (tba, Vienna)
  4. 15:45 – 16:00 Mapping genetic and epigenetic factors influencing human hippocampal gene expression (Per Hoffmann, AT)

16:00-16:30    Coffee Break

16:30-18:00    Biomarkers and Drug Development
                        Chairs: E. Guenther, L. Kenner

  1. 16:30 – 16:55 From Drug Development to Clinical Application (Johannes Czernin, LA, USA)
  2. 16:55 – 17:20 The Role of Imaging Probes in Drug Development (Uwe Haberkorn, Heidelberg)
  3. 17:20 – 17:45 Biomarker and Translational at Boehringer Ingelheim Oncology Discovery Research (Vittoria Zinzalla, IT)
  4. 17:45 – 18:00 The Translational Value of the In Ovo Model for Oncologic Imaging (Theresa Balber, AT)

19:00-23:00    Symposium Dinner at Winery  

Friday               

08:45-10:30    Predictive Biomarkers – The Evidence
                        Chairs: A. Haug, R. Kain

  1. 08:45 – 09:15 Predictive Biomarker in Health Economics (Judit Simon, LBI:AD/MUW)
  2. 09:15 – 09:40 Predictive Biomarkers in Oncology (tba)
  3. 09:40 – 10:05 Predictive Biomarkers in Endocrinology (Ines Fößl, Graz)
  4. 10:05 – 10:30 Predictive Biomarkers in Neuropsychiatry (Henryk Barthel, Leipzig)

10:30-11:00    Coffee Break

11:00-12:30    Big Data & Systems Medicine
                        Chairs: C.Bock, S. Ziegler

  1. 11:00 – 11:25 Selection of Combination Drug Therapies for HIV Patients with machine learning (Thomas Lengauer, Saarbrücken)
  2. 11:25 – 11:50 Data science enabling personalized medicine (Andreas Kremer, Luxembourg)
  3. 11:50 – 12:15 Systems biology for Biomarker Discovery – Empowered by Mass Cytometry and Microfluidics technologies (Muge Akpinar, Fluidigm)
  4. 12:15 – 12:30 The art of multiplex oligonucleotide design (Michaela Hendling, AT)

12:30-14:00    Lunch plus Posters

14:00-15:30    Personalized Medicine and Point-of-Care Diagnostics
                        Chairs: M. Mitterhauser, C. Nöhammer

  1. 14:00 – 14:25 Innovative POC Technologies: An Overview on New Revolutionary Products (Peter Luppa, München)
  2. 14:25 – 14:50 Regulatory Challenges in Diagnostic Kit development
    (Martha Carnielli, TÜV-Süd)
  3. 14:50 – 15:15 Every Sample Has A Story – Sample Collection and Transportation Made Simple (Julia Kappel, Zymo)
  4. 15:15 – 15:30 Combined blood and bone marrow cell-free DNA and disseminated tumor cell detection for sensitive response monitoring and early relapse detection in high-risk neuroblastoma patients (Teresa Gruber, AT)

15:30-16:00    Poster Award, Summary and Closing
                        (Mitterhauser – LBI:AD & Nöhammer – AIT)